Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2012. The document serves as a notification of transactions involving directors or persons discharging managerial responsibility, specifically regarding the SmithKline Beecham Mid-Term Incentive Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific share transaction rather than financial performance results.
Material Changes
No material changes to financial performance or operations are reported in this filing. The only reported change is an increase in the American Depositary Shares (ADSs) held by Mr. E J Gray.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It strictly details a transaction where Mr. E J Gray acquired 17,260 ADSs at a price of $46.01 per ADS following the re-investment of a dividend paid on July 5, 2012.
Investor Verification Points
- Verify the total shareholding of Mr. E J Gray post-transaction.
- Confirm the dividend reinvestment terms under the SmithKline Beecham Mid-Term Incentive Plan.
- Check for subsequent filings regarding other director transactions for the same period.